Literature DB >> 11602553

Molecular enhancement of porcine cardiac chronotropy.

J M Edelberg1, D T Huang, M E Josephson, R D Rosenberg.   

Abstract

OBJECTIVE: To test the potential of gene transfer approaches to enhance cardiac chronotropy in a porcine system as a model of the human heart.
METHODS: Plasmids encoding either the human beta(2) adrenergic receptor or control constructs were injected into the right atria of native Yorkshire pig hearts. Percutaneous electrophysiological recording catheters equipped with 33 gauge circular injection needles were positioned in the mid-lateral right atrium. At the site of the earliest atrial potential the circular injection needles were rotated into the myocardium and the beta(2) adrenergic receptor (n = 6) or control plasmid constructs (n = 5) were injected.
RESULTS: Injection of the beta(2) adrenergic receptor construct significantly enhanced chronotropy compared with control injections. The average (SD) heart rate of the pigs was 108 (16) beats/min before injection. Two days after injection with control plasmids the heart rate was 127 (25) beats/min (NS compared with preinjection rates). After injection with plasmid encoding the beta(2) adrenergic receptor the heart rate increased by 50% to 163 (33) beats/min (p < 0.05 compared with preinjection and postinjection control rates).
CONCLUSIONS: The present studies showed in a large animal model that local targeting of gene expression may be a feasible modality to regulate cardiac pacemaking activity. In addition, these investigations provide an experimental basis for developing future clinical gene transfer approaches to upregulate heart rate and modulate cardiac conduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602553      PMCID: PMC1729967          DOI: 10.1136/heart.86.5.559

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  36 in total

1.  Conditions affecting direct gene transfer into rodent muscle in vivo.

Authors:  J A Wolff; P Williams; G Acsadi; S Jiao; A Jani; W Chong
Journal:  Biotechniques       Date:  1991-10       Impact factor: 1.993

Review 2.  Gene therapy of restenosis: promise and perils.

Authors:  P Libby
Journal:  Circ Res       Date:  1998-02-23       Impact factor: 17.367

3.  Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial.

Authors:  P Alboni; C Menozzi; M Brignole; N Paparella; G Gaggioli; G Lolli; R Cappato
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

4.  The effects of desflurane on cardiac function as measured by conductance volumetry in swine.

Authors:  H Sundeman; M Haney; M Broomé; S Häggmark; G Johansson; O Winsö; B Biber
Journal:  Anesth Analg       Date:  1998-09       Impact factor: 5.108

5.  Disparity of isoflurane effects on left and right ventricular afterload and hydraulic power generation in swine.

Authors:  P M Heerdt; C D Gandhi; M L Dickstein
Journal:  Anesth Analg       Date:  1998-09       Impact factor: 5.108

6.  Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: incidence, clinical features, and long-term evaluation.

Authors:  R Kay; M Estioko; I Wiener
Journal:  Am Heart J       Date:  1982-03       Impact factor: 4.749

7.  The sick sinus syndrome in familial amyloidosis with polyneuropathy.

Authors:  B O Olofsson; P Eriksson; A Eriksson
Journal:  Int J Cardiol       Date:  1983-08       Impact factor: 4.164

Review 8.  Swine in cardiovascular research.

Authors:  H C Hughes
Journal:  Lab Anim Sci       Date:  1986-08

9.  Familial sinus node disease and degenerative myopia--a new hereditary syndrome?

Authors:  A Onat
Journal:  Hum Genet       Date:  1986-02       Impact factor: 4.132

10.  Symptomatic sinus node dysfunction in children without structural heart disease.

Authors:  S M Yabek; T Dillon; W Berman; C J Niland
Journal:  Pediatrics       Date:  1982-05       Impact factor: 7.124

View more
  26 in total

Review 1.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

Review 2.  Creating a cardiac pacemaker by gene therapy.

Authors:  Traian M Anghel; Steven M Pogwizd
Journal:  Med Biol Eng Comput       Date:  2006-12-01       Impact factor: 2.602

Review 3.  Embryological development of pacemaker hierarchy and membrane currents related to the function of the adult sinus node: implications for autonomic modulation of biopacemakers.

Authors:  Tobias Opthof
Journal:  Med Biol Eng Comput       Date:  2007-01-03       Impact factor: 2.602

4.  Biological pacemaking: a concept whose time has come...or is coming.

Authors:  Michael R Rosen
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

5.  A paradigm shift in cardiac pacing therapy?

Authors:  Douglas B Cowan; Francis X McGowan
Journal:  Circulation       Date:  2006-09-05       Impact factor: 29.690

Review 6.  Gene therapy to create biological pacemakers.

Authors:  Gerard J J Boink; Jurgen Seppen; Jacques M T de Bakker; Hanno L Tan
Journal:  Med Biol Eng Comput       Date:  2006-10-18       Impact factor: 2.602

Review 7.  Cardiac gene therapy.

Authors:  Antoine H Chaanine; Jill Kalman; Roger J Hajjar
Journal:  Semin Thorac Cardiovasc Surg       Date:  2010

Review 8.  Cardiac gene therapy with SERCA2a: from bench to bedside.

Authors:  Judith K Gwathmey; Alexan I Yerevanian; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2010-11-18       Impact factor: 5.000

Review 9.  Conference report: building a biologic pacemaker.

Authors:  Michael R Rosen
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

Review 10.  Regenerative therapies in electrophysiology and pacing.

Authors:  Michael R Rosen; Peter R Brink; Ira S Cohen; Peter Danilo; Richard B Robinson; Amy B Rosen; Matthias J Szabolcs
Journal:  J Interv Card Electrophysiol       Date:  2008-03-25       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.